Literature DB >> 21730188

Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data.

Yong Tao1, Jue Ruan, Shiou-Hwei Yeh, Xuemei Lu, Yu Wang, Weiwei Zhai, Jun Cai, Shaoping Ling, Qiang Gong, Zecheng Chong, Zhengzhong Qu, Qianqian Li, Jiang Liu, Jin Yang, Caihong Zheng, Changqing Zeng, Hurng-Yi Wang, Jing Zhang, Sheng-Han Wang, Lingtong Hao, Lili Dong, Wenjie Li, Min Sun, Wei Zou, Caixia Yu, Chaohua Li, Guojing Liu, Lan Jiang, Jin Xu, Huanwei Huang, Chunyan Li, Shuangli Mi, Bing Zhang, Baoxian Chen, Wenming Zhao, Songnian Hu, Shi-Mei Zhuang, Yang Shen, Suhua Shi, Christopher Brown, Kevin P White, Ding-Shinn Chen, Pei-Jer Chen, Chung-I Wu.   

Abstract

We present the analysis of the evolution of tumors in a case of hepatocellular carcinoma. This case is particularly informative about cancer growth dynamics and the underlying driving mutations. We sampled nine different sections from three tumors and seven more sections from the adjacent nontumor tissues. Selected sections were subjected to exon as well as whole-genome sequencing. Putative somatic mutations were then individually validated across all 9 tumor and 7 nontumor sections. Among the mutations validated, 24 were amino acid changes; in addition, 22 large indels/copy number variants (>1 Mb) were detected. These somatic mutations define four evolutionary lineages among tumor cells. Separate evolution and expansion of these lineages were recent and rapid, each apparently having only one lineage-specific protein-coding mutation. Hence, by using a cell-population genetic definition, this approach identified three coding changes (CCNG1, P62, and an indel/fusion gene) as tumor driver mutations. These three mutations, affecting cell cycle control and apoptosis, are functionally distinct from mutations that accumulated earlier, many of which are involved in inflammation/immunity or cell anchoring. These distinct functions of mutations at different stages may reflect the genetic interactions underlying tumor growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730188      PMCID: PMC3141952          DOI: 10.1073/pnas.1108715108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus.

Authors:  M T Hamblin; A Di Rienzo
Journal:  Am J Hum Genet       Date:  2000-04-12       Impact factor: 11.025

2.  The population genetics of ecological specialization in evolving Escherichia coli populations.

Authors:  V S Cooper; R E Lenski
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

3.  Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma.

Authors:  Y J Chen; S H Yeh; J T Chen; C C Wu; M T Hsu; S F Tsai; P J Chen; C H Lin
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 4.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.

Authors:  Lisa G Johnson; Stephen M Schwartz; Mari Malkki; Qin Du; Effie W Petersdorf; Denise A Galloway; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-11       Impact factor: 4.254

6.  Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control.

Authors:  Isabel Novoa; Javier Gallego; Pedro G Ferreira; Raul Mendez
Journal:  Nat Cell Biol       Date:  2010-04-04       Impact factor: 28.824

7.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.

Authors:  Jonathan R Pollack; Therese Sørlie; Charles M Perou; Christian A Rees; Stefanie S Jeffrey; Per E Lonning; Robert Tibshirani; David Botstein; Anne-Lise Børresen-Dale; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

8.  Genome remodelling in a basal-like breast cancer metastasis and xenograft.

Authors:  Li Ding; Matthew J Ellis; Shunqiang Li; David E Larson; Ken Chen; John W Wallis; Christopher C Harris; Michael D McLellan; Robert S Fulton; Lucinda L Fulton; Rachel M Abbott; Jeremy Hoog; David J Dooling; Daniel C Koboldt; Heather Schmidt; Joelle Kalicki; Qunyuan Zhang; Lei Chen; Ling Lin; Michael C Wendl; Joshua F McMichael; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Elizabeth Appelbaum; Katherine Deschryver; Sherri Davies; Therese Guintoli; Li Lin; Robert Crowder; Yu Tao; Jacqueline E Snider; Scott M Smith; Adam F Dukes; Gabriel E Sanderson; Craig S Pohl; Kim D Delehaunty; Catrina C Fronick; Kimberley A Pape; Jerry S Reed; Jody S Robinson; Jennifer S Hodges; William Schierding; Nathan D Dees; Dong Shen; Devin P Locke; Madeline E Wiechert; James M Eldred; Josh B Peck; Benjamin J Oberkfell; Justin T Lolofie; Feiyu Du; Amy E Hawkins; Michelle D O'Laughlin; Kelly E Bernard; Mark Cunningham; Glendoria Elliott; Mark D Mason; Dominic M Thompson; Jennifer L Ivanovich; Paul J Goodfellow; Charles M Perou; George M Weinstock; Rebecca Aft; Mark Watson; Timothy J Ley; Richard K Wilson; Elaine R Mardis
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

9.  Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.

Authors:  Lili Zhao; Tina Samuels; Sarah Winckler; Chandrashekhar Korgaonkar; Van Tompkins; Mary C Horne; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2003-01       Impact factor: 5.852

10.  The ploidy conveyor of mature hepatocytes as a source of genetic variation.

Authors:  Andrew W Duncan; Matthew H Taylor; Raymond D Hickey; Amy E Hanlon Newell; Michelle L Lenzi; Susan B Olson; Milton J Finegold; Markus Grompe
Journal:  Nature       Date:  2010-09-22       Impact factor: 49.962

View more
  68 in total

Review 1.  Targeting cancer-specific mutations by T cell receptor gene therapy.

Authors:  Thomas Blankenstein; Matthias Leisegang; Wolfgang Uckert; Hans Schreiber
Journal:  Curr Opin Immunol       Date:  2015-02-27       Impact factor: 7.486

Review 2.  Emerging patterns of somatic mutations in cancer.

Authors:  Ian R Watson; Koichi Takahashi; P Andrew Futreal; Lynda Chin
Journal:  Nat Rev Genet       Date:  2013-09-11       Impact factor: 53.242

3.  DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes.

Authors:  Yong H Woo; Wen-Hsiung Li
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 4.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

5.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.

Authors:  Peiyong Jiang; Carol W M Chan; K C Allen Chan; Suk Hang Cheng; John Wong; Vincent Wai-Sun Wong; Grace L H Wong; Stephen L Chan; Tony S K Mok; Henry L Y Chan; Paul B S Lai; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

6.  Multiple carcinogenesis contributes to the heterogeneity of HCC.

Authors:  Qiang Gao; Xiao-Ying Wang; Jian Zhou; Jia Fan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-25       Impact factor: 46.802

7.  A bridge between multi-omics data and the management of hepatocellular carcinoma.

Authors:  Naoshi Nishida; Masatoshi Kudo
Journal:  Ann Transl Med       Date:  2015-01

Review 8.  New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next-generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma.

Authors:  Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

9.  Tumour heterogeneity in the clinic.

Authors:  Philippe L Bedard; Aaron R Hansen; Mark J Ratain; Lillian L Siu
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 10.  The cancer antigenome.

Authors:  Bianca Heemskerk; Pia Kvistborg; Ton N M Schumacher
Journal:  EMBO J       Date:  2012-12-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.